At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 3, 2026 at 07:30 ET
Abeona Therapeutics announced it will discuss its fourth quarter and full year 2025 financial results on March 17, 2026, but did not release any actual financial data in this press release. The company highlighted its commercial-stage status with ZEVASKYN® and upcoming participation in the Leerink Global Healthcare Conference.
- Abeona Therapeutics will host an earnings call on March 17, 2026, to discuss Q4 and full year 2025 financial results.
- No financial results were disclosed in this press release.
- The company is commercializing ZEVASKYN®, an autologous cell-based gene therapy for RDEB.
- Management will participate in a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access